AstraZeneca PLC
AZN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000901832
In the last 90 days, AstraZeneca PLC insiders filed 1 open-market purchase and 0 sales; 1,511 institutions reported holding it in 13F filings for Q2 2026, worth $151.3B in total; no superinvestor holds it.
Superinvestors holding AZN, Q2 2026
No superinvestor reported holding AZN in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of AZN each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2026
0 superinvestors holding at quarter end
- Sold out
- Harris Associates (Oakmark)
Q4 2025
1 superinvestor holding at quarter end
Q2 2025
0 superinvestors holding at quarter end
- Sold out
- Soros Fund Management
Q1 2025
1 superinvestor holding at quarter end
- Reduced
- Soros Fund Management (−13.1%)
Q4 2024
1 superinvestor holding at quarter end
- Added
- Soros Fund Management (+19.0%)
Q3 2024
1 superinvestor holding at quarter end
- Added
- Soros Fund Management (+8.2%)
- Sold out
- HHLR Advisors (Hillhouse)
Q2 2024
2 superinvestors holding at quarter end
- New
- HHLR Advisors (Hillhouse)
- Added
- Soros Fund Management (+512.9%)
Q1 2024
1 superinvestor holding at quarter end
Q4 2021
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q3 2021
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−7.3%)
Q2 2021
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−55.6%)